Garvan Institute of Medical Research
Illumina, Garvan Institute Jointly Invest A$27M in Single-Cell Disease Research
Illumina is supporting the Garvan Institute's TenK10K project with supplies, equipment, and research technical support through its joint investment.
Garvan Institute Gets A$11.6M From Australian Government to Develop Genomics-Based Disease Tests
Four teams will use genomics to improve the diagnosis and treatment of diseases including Parkinson's, inflammatory bowel disease, and rare genetic disorders.
Sarcoma Susceptibility Traced to Telomere Function, Mitotic Pathways
A search for rare sarcoma-related germline variants led to centromere and shelterin genes involved in mitotic function and telomere regulation, respectively.
Triple-Negative Breast Cancer Treatment Hints Drawn From Single-Cell Study
Tumor microenvironment cell transcriptomes pointed to four stromal cell clusters, including immune interacting support cells predicted to impact immunotherapy response.
GnomAD Consortium Details Range of Human Genetic Variation From Large Dataset
The collection of more than 125,000 exomes and 15,000 genomes has enabled an analysis of loss-of-function variants, may help diagnose rare disease, and guide drug development.